Clinical trial
Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic…
NCT00001765 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001765 |
|---|---|
| Title | Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease |
| Official title | Low Intensity Preparative Regimen Followed by HLA-Matched, Mobilized Peripheral Blood Stem Cell Transplantation for Chronic Granulomatous Disease |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Granulomatous Disease |
| Intervention type | Device |
| Interventions | Nexell Isolex with T-cell Depletion, Baxter isolex 300i |
| Enrollment | 60 |
| Start date | Apr 1, 1998 |
| Completion | Feb 1, 2005 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: